Trexquant Investment LP Charles River Laboratories International, Inc. Transaction History

Trexquant Investment LP

$8.35 Billion
Q2 2025

A detailed history of Trexquant Investment LP transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Trexquant Investment LP holds 61,315 shares of CRL stock, worth $11.5 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares

61,315

Previous 21,671 182.94%

Holding current value

$11.5 Million

Previous $3.26 Million 185.28%

% of portfolio

0.11%

Previous 0.04%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 12, 2025	BUY	$99.75 - $151.89 $3.95 Million - $6.02 Million	39,644 Added 182.94%	61,315 $9.3 Million
Q1 2025 May 14, 2025	SELL	$150.52 - $190.14 $11.8 Million - $14.9 Million	-78,606 Reduced 78.39%	21,671 $3.26 Million
Q4 2024 Feb 12, 2025	BUY	$178.58 - $220.69 $14.6 Million - $18 Million	81,714 Added 440.2%	100,277 $18.5 Million
Q3 2024 Nov 12, 2024	BUY	$187.96 - $245.29 $1.96 Million - $2.56 Million	10,440 Added 128.52%	18,563 $3.66 Million
Q2 2024 Aug 13, 2024	BUY	$206.39 - $268.73 $1.68 Million - $2.18 Million	8,123 New	8,123 $1.68 Million
Q3 2023 Nov 13, 2023	BUY	$194.44 - $217.61 $4.07 Million - $4.56 Million	20,942 New	20,942 $4.1 Million
Q1 2023 May 15, 2023	BUY	$191.89 - $259.92 $4.84 Million - $6.56 Million	25,233 New	25,233 $5.09 Million
Q2 2022 Aug 11, 2022	SELL	$204.13 - $302.4 $3.07 Million - $4.54 Million	-15,019 Reduced 85.77%	2,492 $533,000
Q1 2022 May 13, 2022	BUY	$255.51 - $362.11 $4.16 Million - $5.9 Million	16,300 Added 1346.0%	17,511 $4.97 Million
Q4 2021 Feb 14, 2022	BUY	$351.38 - $448.68 $425,521 - $543,351	1,211 New	1,211 $456,000
Q3 2020 Nov 06, 2020	SELL	$175.56 - $226.45 $725,413 - $935,691	-4,132 Closed	0 $0
Q2 2020 Aug 07, 2020	BUY	$118.84 - $189.72 $301,734 - $481,699	2,539 Added 159.38%	4,132 $720,000
Q1 2020 May 08, 2020	BUY	$98.9 - $178.34 $157,547 - $284,095	1,593 New	1,593 $201,000
Q3 2019 Nov 08, 2019	SELL	$125.07 - $143.67 $1.04 Million - $1.19 Million	-8,307 Closed	0 $0
Q2 2019 Aug 09, 2019	BUY	$123.4 - $148.55 $173,500 - $208,861	1,406 Added 20.37%	8,307 $1.18 Million
Q1 2019 May 13, 2019	SELL	$104.82 - $146.73 $1.16 Million - $1.62 Million	-11,044 Reduced 61.54%	6,901 $1 Million
Q4 2018 Feb 13, 2019	BUY	$105.09 - $137.23 $1.89 Million - $2.46 Million	17,945 New	17,945 $2.03 Million
Q3 2018 Nov 09, 2018	SELL	$112.11 - $134.54 $1.01 Million - $1.21 Million	-9,013 Closed	0 $0
Q2 2018 Aug 07, 2018	BUY	$102.37 - $117.25 $420,638 - $481,780	4,109 Added 83.79%	9,013 $1.01 Million
Q1 2018 May 03, 2018	BUY	$98.19 - $115.2 $481,523 - $564,940	4,904 New	4,904 $523,000

Others Institutions Holding CRL

# of Institutions

627

Shares Held

52.5M

Call Options Held

1.42M

Put Options Held

1.42M

View Full List

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $9.58B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

More about CRL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Trexquant Investment LP, based on Form 13F filings with the SEC.

News

Stay updated on Trexquant Investment LP with notifications on news.

Account

Trexquant Investment LP Charles River Laboratories International, Inc. Transaction History